Login to Your Account

Gentium Voluntarily Pulls NDA For Defibrotide; Shares Tumble

By Marie Powers

Friday, August 19, 2011
Shares of Gentium SpA slid Thursday after the company revealed it had voluntarily withdrawn the new drug application (NDA) for lead product candidate defibrotide.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription